BioSpace News Archive

Lubrizol Advanced Materials, Inc., inventors and the largest manufacturers of CPVC compound worldwide, and Prince Pipes and Fittings Ltd., announced , the signing of a FlowGuard® CPVC Processor agreement for the manufacturing and sale of Prince FlowGuard® Plus CPVC pipes and fittings in India.

Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for the treatment of cancer, today announced the appointment of Stephen Dale, M.D., as Chief Medical Officer. Dr. Dale joins Kura most recently from Kyowa Kirin, where he served as Senior Vice President and Global Head of Medical Science with a primary focus in oncology. “I am delighted that Stephen is joining Kura to le

AlloVir, Inc. (Nasdaq: ALVR), a late clinical-stage cell therapy company, will present a corporate overview at the virtual Morgan Stanley 18 th Annual Global Healthcare Conference on September 17, 2020 at 5:00 p.m. ET. A live webcast of the presentation will be available on the Investors & Press section of the AlloVir website at https://ir.allovir.com . An archived replay of the webcast will be available for approximately 30 days fo

Sonnet BioTherapeutics Holdings, Inc. announced today that, as part of the previously announced warrant exchange agreement, all 3,300,066 Series A Warrants have been exercised at a price of $3.19 per share. Gross proceeds to the Company were $10.5 Million.

Population health leader warns that falling behind on children’s immunization schedules during the COVID-19 pandemic could lead to outbreaks of infectious diseases such as mumps, measles and pertussis

DSG3-CAART achieved autoantibody elimination and resolution of blisters in active immune mouse model of pemphigus vulgaris Soluble autoantibodies demonstrated potential to enhance DSG3-CAART efficacy and did not demonstrate off-target toxicity DesCAARTes™ Phase 1 clinical trial actively recruiting patients PHILADELPHIA, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T c

Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a medical technology and digital health company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders, today announced it will be participating in SLEEP 2020, the annual meeting of the American Academy of Sleep Medicine, which is taking place virtually on August 27-30, 2020. “We are looking forward to

Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing technologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming, today announced that it has appointed Namvar Kiaie to the Company’s Board of Directors, effective as of July 2, 2020. Aditxt’s

Prometheus Biosciences, Inc., (“Prometheus”) a biopharmaceutical company committed to the discovery, development, and commercialization of a broad portfolio of novel precision therapeutics and companion diagnostics for patients living with Inflammatory Bowel Disease (IBD), announced today the appointment of Joseph C. Papa to its Board

Cardiovascular implants are used to treat heart diseases. Implantable devices are sophisticated modern devices that provide patients with several benefits.